Alberto Cambieri

946 total citations
6 papers, 790 citations indexed

About

Alberto Cambieri is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Alberto Cambieri has authored 6 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 3 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Alberto Cambieri's work include Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Alberto Cambieri is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Alberto Cambieri collaborates with scholars based in Italy, United Kingdom and Japan. Alberto Cambieri's co-authors include Giorgio V. Scagliotti, Marco Volante, Silvia Novello, Paolo Ceppi, Silvia Saviozzi, Ida Rapa, Marco Lo Iacono, Mauro Papotti, Susanna Cappia and Raffaele Calogero and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Alberto Cambieri

6 papers receiving 764 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alberto Cambieri Italy 6 512 470 336 195 75 6 790
F. Cardenal Spain 8 632 1.2× 585 1.2× 416 1.2× 202 1.0× 88 1.2× 26 946
Ivana Sullivan Spain 14 322 0.6× 509 1.1× 218 0.6× 100 0.5× 47 0.6× 55 686
J.M. Sánchez-Torres Spain 13 428 0.8× 614 1.3× 150 0.4× 104 0.5× 43 0.6× 21 772
Tejas Patil United States 16 624 1.2× 544 1.2× 228 0.7× 161 0.8× 66 0.9× 67 836
DuyKhanh Pham United States 7 1.0k 2.0× 681 1.4× 298 0.9× 170 0.9× 126 1.7× 10 1.2k
Takumi Yamaura Japan 13 215 0.4× 329 0.7× 200 0.6× 172 0.9× 63 0.8× 38 603
Carme Sarries Spain 7 252 0.5× 301 0.6× 469 1.4× 231 1.2× 58 0.8× 10 718
B. E. Johnson United States 12 388 0.8× 359 0.8× 209 0.6× 101 0.5× 22 0.3× 17 534
R. Metzger United States 4 234 0.5× 360 0.8× 300 0.9× 106 0.5× 141 1.9× 4 612
Antonella Flacco Italy 9 482 0.9× 381 0.8× 269 0.8× 179 0.9× 47 0.6× 13 623

Countries citing papers authored by Alberto Cambieri

Since Specialization
Citations

This map shows the geographic impact of Alberto Cambieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Cambieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Cambieri more than expected).

Fields of papers citing papers by Alberto Cambieri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Cambieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Cambieri. The network helps show where Alberto Cambieri may publish in the future.

Co-authorship network of co-authors of Alberto Cambieri

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Cambieri. A scholar is included among the top collaborators of Alberto Cambieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Cambieri. Alberto Cambieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Saviozzi, Silvia, Paolo Ceppi, Silvia Novello, et al.. (2009). Non–Small Cell Lung Cancer Exhibits Transcript Overexpression of Genes Associated with Homologous Recombination and DNA Replication Pathways. Cancer Research. 69(8). 3390–3396. 58 indexed citations
2.
Scagliotti, Giorgio V., Valentina Monica, Paolo Ceppi, et al.. (2009). Baseline thymidylate synthase expression according to histological subtypes of non-small cell lung cancer. Journal of Clinical Oncology. 27(15_suppl). 7521–7521. 12 indexed citations
3.
Ceppi, Paolo, Silvia Novello, Alberto Cambieri, et al.. (2009). Polymerase η mRNA Expression Predicts Survival of Non–Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy. Clinical Cancer Research. 15(3). 1039–1045. 88 indexed citations
4.
Monica, Valentina, Giorgio V. Scagliotti, Paolo Ceppi, et al.. (2009). Differential Thymidylate Synthase Expression in Different Variants of Large-Cell Carcinoma of the Lung. Clinical Cancer Research. 15(24). 7547–7552. 59 indexed citations
5.
Ceppi, Paolo, Marco Volante, Silvia Saviozzi, et al.. (2006). Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase. Cancer. 107(7). 1589–1596. 303 indexed citations
6.
Ceppi, Paolo, Marco Volante, Silvia Novello, et al.. (2006). ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine. Annals of Oncology. 17(12). 1818–1825. 270 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026